ArticleInternational journal of oncology2018

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.

Magdalena Absmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.